Health Pl
Health Blog

Can Stem Cells Treat Sciatica?

Sciatica is a form of lower back pain that radiates from the sciatic nerve down through the hips and buttocks. Typically, it affects one side of the body and has an underlying cause such as a herniated disc, which compresses the nerve. Other possible root causes of sciatica include:

While there are treatments available such as medication and physical therapy, patients whose daily routines have been disrupted by the condition may seek other treatment options.

For ongoing pain and discomfort caused by sciatica, some patients are turning to stem cell therapy. Moreover, addressing sciatica early may help to prevent lasting damage such as muscle weakness, loss of mobility and sensation, and other effects.

As the body’s master cells which can give rise to any specialized cell types, stem cells can be harvested from a patient’s own tissue (adipose) or a donated umbilical cord tissue source (Wharton’s Jelly) and strategically injected to the site of an injury. There, they can repair and replace compromised tissue to address issues such as pain and reduced mobility. This form of regenerative medicine aims to help patients who have had unsuccessful outcomes through treatments such as physical therapy or those who would like to delay or prevent the need for invasive surgeries.

By focusing on regenerating the damaged tissue, stem cell therapy helps patients achieve decreased chronic pain, improvement in function, and an increase in strength and abilities. Whether you’ve recently started experiencing the symptoms of sciatica or have been struggling with them for years, stem cell therapy is an alternative option that can help you pursue your journey towards wellness.

This post was written by a medical professional at Stemedix Inc. At Stemedix we provide access to Regenerative Medicine for back pain, also known as degenerative disc disease. Regenerative medicine has the natural potential to help improve symptoms sometimes lost from the progression of many conditions.

Comments are closed.